CRISPR Therapeutics AG (CRSP) Treasury Shares (2015 - 2026)

CRISPR Therapeutics AG has disclosed Treasury Shares across 9 years of filings, most recently posting $60000.0 for Q1 2026.

• Treasury Shares for Q1 2026 came in at $60000.0, down 3.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $60000.0 (down 3.23% YoY), and the FY2025 annual result was $60000.0, down 3.23% from the prior year.
• Treasury Shares came in at $60000.0 for Q1 2026 at CRISPR Therapeutics AG, roughly flat from $60000.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.1 million in Q1 2024 to a low of $115316.0 in Q1 2026.
• The 5-year median for Treasury Shares is $180316.0 (2022), against an average of $801324.4.
• Across the five-year window, Treasury Shares changed 0.0% in 2022 and declined 3.23% in 2025, its largest moves.
• CRISPR Therapeutics AG's Treasury Shares stood at $63000.0 in 2022, then retreated by 1.59% to $62000.0 in 2023, then changed by 0.0% to $62000.0 in 2024, then decreased by 3.23% to $60000.0 in 2025, then changed by 0.0% to $60000.0 in 2026.
• The last three Treasury Shares figures came in at $60000.0 (Q1 2026), $60000.0 (Q4 2025), and $60000.0 (Q3 2025), per Business Quant data.